MLSS Milestone Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MLSS

Price (delayed)

$0.3945

Market cap

$34.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$34.54M

?
Relative Growth: Rel. Growth: 43
Relative Strength: Rel. Strength: 53
Relative Valuation: Rel. Valuation: 15
Relative Profitability: Rel. Profitability: 25

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary ...

Highlights
Milestone Scientific's EPS has increased by 29% from the previous quarter and by 29% YoY
The net income has grown by 20% since the previous quarter and by 13% year-on-year
The equity has contracted by 49% YoY and by 19% from the previous quarter
The company's quick ratio fell by 42% YoY and by 18% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.milestonescientific.com
Peers: APT XRAY ALGN

Key stats

What are the main financial stats of MLSS

MLSS stock price

How has the Milestone Scientific stock price performed over time
Intraday
3.3%
1 week
12.75%
1 month
12.71%
1 year
-40.8%
YTD
44.51%
QTD
22.9%

Financial performance

How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.9M
Gross profit
$6.32M
Operating income
-$4.53M
Net income
-$4.57M
Gross margin
71%
Net margin
-51.3%
The operating margin has increased by 40% year-on-year and by 20% since the previous quarter
MLSS's operating income is up by 38% year-on-year and by 21% since the previous quarter
The net margin has grown by 20% from the previous quarter and by 16% YoY
The net income has grown by 20% since the previous quarter and by 13% year-on-year

Price vs fundamentals

How does MLSS's price correlate with its fundamentals

Growth

What is Milestone Scientific's growth rate over time

Valuation

What is Milestone Scientific stock price valuation
P/E
N/A
P/B
13.89
P/S
3.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.88
Milestone Scientific's EPS has increased by 29% from the previous quarter and by 29% YoY
The P/B is 62% higher than the 5-year quarterly average of 8.6 and 19% higher than the last 4 quarters average of 11.7
The equity has contracted by 49% YoY and by 19% from the previous quarter
The P/S is 46% less than the 5-year quarterly average of 7.0
The revenue is up by 3.4% year-on-year

Efficiency

How efficient is Milestone Scientific business performance
The return on equity has dropped by 101% year-on-year but it has increased by 4.4% since the previous quarter
The company's return on invested capital rose by 30% YoY and by 22% QoQ
Milestone Scientific's ROS has increased by 20% from the previous quarter and by 17% YoY
MLSS's ROA is up by 17% QoQ but it is down by 13% YoY

Dividends

What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MLSS.

Financial health

How did Milestone Scientific financials performed over time
The total assets is 40% greater than the total liabilities
The company's quick ratio fell by 42% YoY and by 18% QoQ
The total liabilities has increased by 23% year-on-year and by 14% since the previous quarter
The debt is 57% less than the equity
The equity has contracted by 49% YoY and by 19% from the previous quarter
Milestone Scientific's debt to equity has increased by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.